Deficient DNASE1L3 (an extracellular DNase) facilitates HCC invasion through NET formation by activating GMP-AMP synthase in circulation and the non-canonical pathway of NF-kappa B in diabetic HCC (47). Here, DNASE1L3 is linked to hepatocellular carcinoma.